SCM
MRK icon

Soleus Capital Management’s Merck MRK Stock Holding History

Soleus Capital Management’s Portfolio MRK Stock Details MRK Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$6.42M Sell
50,000
-153,000
-75% -$17.9M 0.22% 71
2026
Q1 		$24.4M Buy
+203,000
New +$23.4M 0.99% 27
2021
Q2 		– Sell
-31,551
Closed -$2.32M – 71
2021
Q1 		$2.32M Buy
31,551
+1,782
+6% +$131K 0.42% 46
2020
Q4 		$2.32M Buy
29,769
+1,914
+7% +$146K 0.31% 34
2020
Q3 		$2.21M Buy
+27,855
New +$2.18M 1.17% 30

Other funds holding MRK

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Charles Schwab
Charles Schwab San Francisco, California $751B AUM 38.74% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Soleus Capital Management's MRK Position: Q2 2026 in Review

Soleus Capital Management reduced its Merck (MRK) stake by 75% in Q2 2026, selling an estimated $17.9M and leaving 50,000 shares worth $6.42M. The position accounts for 0.22% of the portfolio, ranked #71.

Soleus Capital Management first reported a position in MRK in Q3 2020 and has held it in 5 quarters since. The position peaked at $24.4M in Q1 2026. 3,833 funds tracked by Wall St. Rank hold MRK as of Q2 2026.

  • Soleus Capital Management held 50,000 shares of Merck worth $6.42M as of Q2 2026.
  • Soleus Capital Management sold 153,000 Merck shares in Q2 2026, an estimated $17.9M.
  • Merck made up 0.22% of Soleus Capital Management's portfolio in Q2 2026, its #71 holding.
  • Soleus Capital Management first reported a position in Merck in Q3 2020 and has held it in 5 quarters since.
  • Soleus Capital Management's Merck position peaked at $24.4M in Q1 2026.
  • 3,833 funds tracked by Wall St. Rank held Merck as of Q2 2026.

Based on Soleus Capital Management's 13F filing for Q2 2026, filed 11 Aug 2026.